Lv1
18 积分 2024-04-13 加入
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2天前
已完结
Dual-Targeting BCMA-CD19 CAR-T Cell Therapy in Systemic Lupus Erythematosus: Single-Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution
11天前
已完结
Reply: BCMA – CD19 CAR T Cells in Systemic Lupus Erythematosus: Humoral Reset or Antigen‐Specific Tolerance?
12天前
已完结
IL-7 and CD4 T Follicular Helper Cells in HIV-1 Infection
12天前
已完结
The Evolving Landscape of CAR T-Cell Therapy in Autoimmune Diseases: A State-of-the-Art Review (2025)
12天前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
23天前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
24天前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
24天前
已完结
皖公网安备34019202002308
